BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elgner F, Ren H, Medvedev R, Ploen D, Himmelsbach K, Boller K, Hildt E. The Intracellular Cholesterol Transport Inhibitor U18666A Inhibits the Exosome-Dependent Release of Mature Hepatitis C Virus. J Virol 2016;90:11181-96. [PMID: 27707921 DOI: 10.1128/JVI.01053-16] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Bender D, Glitscher M, Hildt E. [Viral hepatitis A to E: prevalence, pathogen characteristics, and pathogenesis]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021. [PMID: 34932130 DOI: 10.1007/s00103-021-03472-0] [Reference Citation Analysis]
2 García-Sanz P, M F G Aerts J, Moratalla R. The Role of Cholesterol in α-Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease. Mov Disord 2021;36:1070-85. [PMID: 33219714 DOI: 10.1002/mds.28396] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Syed GH, Khan M, Yang S, Siddiqui A. Hepatitis C Virus Lipoviroparticles Assemble in the Endoplasmic Reticulum (ER) and Bud off from the ER to the Golgi Compartment in COPII Vesicles. J Virol 2017;91:e00499-17. [PMID: 28515296 DOI: 10.1128/JVI.00499-17] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 5.2] [Reference Citation Analysis]
4 Charlton FW, Hover S, Fuller J, Hewson R, Fontana J, Barr JN, Mankouri J. Cellular cholesterol abundance regulates potassium accumulation within endosomes and is an important determinant in bunyavirus entry. J Biol Chem 2019;294:7335-47. [PMID: 30804209 DOI: 10.1074/jbc.RA119.007618] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
5 Bender D, Hildt E. Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis. Int J Mol Sci 2019;20:E4659. [PMID: 31546975 DOI: 10.3390/ijms20184659] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
6 Bunz M, Ritter M, Schindler M. HCV egress - unconventional secretion of assembled viral particles. Trends Microbiol 2021:S0966-842X(21)00190-6. [PMID: 34483048 DOI: 10.1016/j.tim.2021.08.005] [Reference Citation Analysis]
7 Meneses-Salas E, García-Melero A, Kanerva K, Blanco-Muñoz P, Morales-Paytuvi F, Bonjoch J, Casas J, Egert A, Beevi SS, Jose J, Llorente-Cortés V, Rye KA, Heeren J, Lu A, Pol A, Tebar F, Ikonen E, Grewal T, Enrich C, Rentero C. Annexin A6 modulates TBC1D15/Rab7/StARD3 axis to control endosomal cholesterol export in NPC1 cells. Cell Mol Life Sci 2020;77:2839-57. [PMID: 31664461 DOI: 10.1007/s00018-019-03330-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
8 Dogrammatzis C, Waisner H, Kalamvoki M. Cloaked Viruses and Viral Factors in Cutting Edge Exosome-Based Therapies. Front Cell Dev Biol 2020;8:376. [PMID: 32528954 DOI: 10.3389/fcell.2020.00376] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
9 Doki T, Tarusawa T, Hohdatsu T, Takano T. In Vivo Antiviral Effects of U18666A Against Type I Feline Infectious Peritonitis Virus. Pathogens 2020;9:E67. [PMID: 31963705 DOI: 10.3390/pathogens9010067] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
10 Vieyres G, Pietschmann T. HCV Pit Stop at the Lipid Droplet: Refuel Lipids and Put on a Lipoprotein Coat before Exit. Cells 2019;8:E233. [PMID: 30871009 DOI: 10.3390/cells8030233] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
11 Wu Q, Cortez L, Kamali-Jamil R, Sim V, Wille H, Kar S. Implications of exosomes derived from cholesterol-accumulated astrocytes in Alzheimer's disease pathology. Dis Model Mech 2021;14:dmm048929. [PMID: 34524402 DOI: 10.1242/dmm.048929] [Reference Citation Analysis]
12 Li G, Su B, Fu P, Bai Y, Ding G, Li D, Wang J, Yang G, Chu B. NPC1-regulated dynamic of clathrin-coated pits is essential for viral entry. Sci China Life Sci 2021. [PMID: 34047913 DOI: 10.1007/s11427-021-1929-y] [Reference Citation Analysis]
13 Sabino C, Basic M, Bender D, Elgner F, Himmelsbach K, Hildt E. Bafilomycin A1 and U18666A Efficiently Impair ZIKV Infection. Viruses 2019;11:E524. [PMID: 31174294 DOI: 10.3390/v11060524] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
14 Fernández de Castro I, Tenorio R, Ortega-González P, Knowlton JJ, Zamora PF, Lee CH, Fernández JJ, Dermody TS, Risco C. A modified lysosomal organelle mediates nonlytic egress of reovirus. J Cell Biol 2020;219:e201910131. [PMID: 32356864 DOI: 10.1083/jcb.201910131] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
15 Sturley SL, Rajakumar T, Hammond N, Higaki K, Márka Z, Márka S, Munkacsi AB. Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity. J Lipid Res 2020;61:972-82. [PMID: 32457038 DOI: 10.1194/jlr.R120000851] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
16 Shi Y, Du L, Lv D, Li Y, Zhang Z, Huang X, Tang H. Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases. J Gastroenterol 2021;56:336-49. [PMID: 33665710 DOI: 10.1007/s00535-021-01765-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Liu H, Li B. The functional role of exosome in hepatocellular carcinoma. J Cancer Res Clin Oncol 2018;144:2085-95. [PMID: 30062486 DOI: 10.1007/s00432-018-2712-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
18 Ding J, Wang J, Chen J. Exosomes as therapeutic vehicles in liver diseases. Ann Transl Med 2021;9:735. [PMID: 33987433 DOI: 10.21037/atm-20-5422] [Reference Citation Analysis]
19 Elgner F, Sabino C, Basic M, Ploen D, Grünweller A, Hildt E. Inhibition of Zika Virus Replication by Silvestrol. Viruses 2018;10:E149. [PMID: 29584632 DOI: 10.3390/v10040149] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
20 Yu T, Yang Q, Tian F, Chang H, Hu Z, Yu B, Han L, Xing Y, Jiu Y, He Y, Zhong J. Glycometabolism regulates hepatitis C virus release. PLoS Pathog 2021;17:e1009746. [PMID: 34297778 DOI: 10.1371/journal.ppat.1009746] [Reference Citation Analysis]
21 Fernández-Oliva A, Ortega-González P, Risco C. Targeting host lipid flows: Exploring new antiviral and antibiotic strategies. Cell Microbiol 2019;21:e12996. [PMID: 30585688 DOI: 10.1111/cmi.12996] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
22 Bley H, Schöbel A, Herker E. Whole Lotta Lipids-from HCV RNA Replication to the Mature Viral Particle. Int J Mol Sci 2020;21:E2888. [PMID: 32326151 DOI: 10.3390/ijms21082888] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
23 Salata C, Calistri A, Parolin C, Baritussio A, Palù G. Antiviral activity of cationic amphiphilic drugs. Expert Rev Anti Infect Ther 2017;15:483-92. [PMID: 28286997 DOI: 10.1080/14787210.2017.1305888] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 13.8] [Reference Citation Analysis]
24 Croce C, Garrido F, Dinamarca S, Santi-rocca J, Marion S, Blanchard N, Mayorga LS, Cebrian I. Efficient Cholesterol Transport in Dendritic Cells Defines Optimal Exogenous Antigen Presentation and Toxoplasma gondii Proliferation. Front Cell Dev Biol 2022;10:837574. [DOI: 10.3389/fcell.2022.837574] [Reference Citation Analysis]
25 Cashikar AG, Hanson PI. A cell-based assay for CD63-containing extracellular vesicles. PLoS One 2019;14:e0220007. [PMID: 31339911 DOI: 10.1371/journal.pone.0220007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
26 Khan N, Chen X, Geiger JD. Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments. Front Pharmacol 2020;11:595888. [PMID: 33324224 DOI: 10.3389/fphar.2020.595888] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
27 Elgner F, Hildt E, Bender D. Relevance of Rab Proteins for the Life Cycle of Hepatitis C Virus. Front Cell Dev Biol 2018;6:166. [PMID: 30564577 DOI: 10.3389/fcell.2018.00166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Glitscher M, Hildt E. Endosomal Cholesterol in Viral Infections - A Common Denominator? Front Physiol 2021;12:750544. [PMID: 34858206 DOI: 10.3389/fphys.2021.750544] [Reference Citation Analysis]
29 Kapustin AN, Davey P, Longmire D, Matthews C, Linnane E, Rustogi N, Stavrou M, Devine PWA, Bond NJ, Hanson L, Sonzini S, Revenko A, MacLeod AR, Ross S, Chiarparin E, Puri S. Antisense oligonucleotide activity in tumour cells is influenced by intracellular LBPA distribution and extracellular vesicle recycling. Commun Biol 2021;4:1241. [PMID: 34725463 DOI: 10.1038/s42003-021-02772-0] [Reference Citation Analysis]
30 Takano T, Endoh M, Fukatsu H, Sakurada H, Doki T, Hohdatsu T. The cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infection. Antiviral Res 2017;145:96-102. [PMID: 28780424 DOI: 10.1016/j.antiviral.2017.07.022] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
31 Fan H, Qiao L, Kang KD, Fan J, Wei W, Luo G. Attachment and Postattachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission. J Virol. 2017;91. [PMID: 28404852 DOI: 10.1128/jvi.00280-17] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
32 Papatheodorou P, Kindig S, Badilla-Lobo A, Fischer S, Durgun E, Thuraisingam T, Witte A, Song S, Aktories K, Chaves-Olarte E, Rodríguez C, Barth H. The Compound U18666A Inhibits the Intoxication of Cells by Clostridioides difficile Toxins TcdA and TcdB. Front Microbiol 2021;12:784856. [PMID: 34912322 DOI: 10.3389/fmicb.2021.784856] [Reference Citation Analysis]
33 Stoeck IK, Lee JY, Tabata K, Romero-Brey I, Paul D, Schult P, Lohmann V, Kaderali L, Bartenschlager R. Hepatitis C Virus Replication Depends on Endosomal Cholesterol Homeostasis. J Virol 2018;92:e01196-17. [PMID: 29046459 DOI: 10.1128/JVI.01196-17] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 7.2] [Reference Citation Analysis]
34 Haberger V, Elgner F, Roos J, Bender D, Hildt E. Regulation of the Transferrin Receptor Recycling in Hepatitis C Virus-Replicating Cells. Front Cell Dev Biol 2020;8:44. [PMID: 32117974 DOI: 10.3389/fcell.2020.00044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Joshi BS, de Beer MA, Giepmans BNG, Zuhorn IS. Endocytosis of Extracellular Vesicles and Release of Their Cargo from Endosomes. ACS Nano 2020;14:4444-55. [PMID: 32282185 DOI: 10.1021/acsnano.9b10033] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 32.0] [Reference Citation Analysis]